Get the Stockscreener App
28.15
23.73%
-8.76
Azenta Inc stock is traded at $28.15, with a volume of 2.00M.
It is down -23.73% in the last 24 hours and down -15.69% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$36.91
Open:
$32.05
24h Volume:
2.00M
Relative Volume:
2.96
Market Cap:
$1.29B
Revenue:
$604.93M
Net Income/Loss:
$-31.91M
P/E Ratio:
-11.63
EPS:
-2.42
Net Cash Flow:
$45.67M
1W Performance:
-27.88%
1M Performance:
-15.69%
6M Performance:
-13.14%
1Y Performance:
-45.83%
1-Day Range:
$27.00
$32.17
1-Week Range:
$27.00
$39.86
52-Week Range:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
28.12 | 1.70B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
478.42 | 169.76B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
208.56 | 58.83B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.89 | 37.98B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
263.00 | 36.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.37 | 37.22B | 27.43B | 1.27B | 1.01B | 1.5829 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Azenta shares slide after Q1 earnings come in below forecasts - MSN
Azenta Q1 2026 slides: Revenue edges up 1% while organic growth declines, stock plunges - Investing.com
Azenta Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Azenta Q1 2026 misses EPS, stock falls By Investing.com - Investing.com India
Azenta's (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue - Finviz
Azenta: Q1 Earnings Insights - Benzinga
Earnings Flash (AZTA) Azenta, Inc. Reports Q1 Revenue $149.0M, vs. FactSet Est of $147.1M - marketscreener.com
Azenta shares fall 6% as first quarter earnings miss estimates By Investing.com - Investing.com Nigeria
Azenta shares fall 6% as first quarter earnings miss estimates - Investing.com
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 - PR Newswire
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 15.91% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Azenta (AZTA) To Report Earnings Tomorrow: Here Is What To Expect - TradingView
Azenta director Alan P. Malus resigns from board for new full-time role - Investing.com
Privia Health Group (NASDAQ:PRVA) & Azenta (NASDAQ:AZTA) Financial Analysis - Defense World
Is Azenta (AZTA) Offering Value After A 16% One Month Share Price Jump - Yahoo Finance
Head-To-Head Survey: 10x Genomics (NASDAQ:TXG) & Azenta (NASDAQ:AZTA) - Defense World
Why Are Azenta (AZTA) Shares Soaring Today - Barchart.com
Azenta Shareholders Reaffirm Board, Pay Plans and Auditor - The Globe and Mail
Can Azenta Inc. maintain its current growth ratePortfolio Return Summary & Free Community Consensus Stock Picks - Mfd.ru
Critical Comparison: Azenta (NASDAQ:AZTA) versus Enovis (NYSE:ENOV) - Defense World
Azenta Emerges In Nasdaq composite Discussion Around Research Enablement - Kalkine Media
Azenta (NASDAQ:AZTA) Upgraded at Zacks Research - Defense World
Stock Market Recap: Is Azenta Inc stock trending bullishJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - baoquankhu1.vn
Azenta (AZTA) Expected to Announce Earnings on Wednesday - MarketBeat
Short Covering: Is TUSK a stock for growth or value investorsProduct Launch & Safe Entry Zone Identification - baoquankhu1.vn
Bull Run: Can Azenta Inc keep up with sector leadersBuy Signal & Low Drawdown Investment Ideas - baoquankhu1.vn
Market Review: Is Crawford Company stock suitable for long term investingPortfolio Gains Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast - Finviz
Azenta (AZTA) to Announce Q1 2026 Earnings on February 4, 2026 - Intellectia AI
Azenta Delays 10-K Filing Due to Accounting Revisions - MSN
Aug Setups: What is the dividend yield of Azenta IncTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Stephens Investment Management Group LLC Grows Stake in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. $AZTA Shares Purchased by Nordea Investment Management AB - MarketBeat
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 15.88% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
IBD rating upgrades: Azenta flashes improved price strength - MSN
Conestoga Capital Advisors LLC Sells 450,370 Shares of Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Why Azenta (AZTA) Got an Analyst Upgrade After Mixed Results and What It Implies for Automation - Sahm
Why Azenta Inc. stock is seen as undervalued2025 Big Picture & Community Verified Trade Alerts - ulpravda.ru
TD Cowen Raises Azenta (NASDAQ:AZTA) Price Target to $39.00 - MarketBeat
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News - GuruFocus
Buyback Watch: How Azenta Inc. stock performs in rising dollar environmentTrade Analysis Summary & Low Drawdown Investment Strategies - Улправда
Market Outlook: Will Azenta Inc. stock deliver consistent dividendsJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta Enters Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - citybiz
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta (NASDAQ:AZTA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Bear of the Day: Azenta (AZTA) - The Globe and Mail
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Azenta divests B Medical Systems to streamline portfolio - The Globe and Mail
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
1.48%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):